Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


PanOptica
150 Morristown Road, Suite 205
Bernardsville, NJ 07924
Phone: 908-766-2202
http://panopticapharma.com/

PanOptica, Inc., is a private biopharmaceutical company focused on developing innovative ophthalmology therapies. Investors include Third Rock Ventures, Novo Ventures, and SV Life Sciences. The company was co-founded by Paul Chaney, past president of OSI-Eyetech, and Martin Wax, MD, a noted academic clinician scientist working in glaucoma, and most recently vice president of research and development and head of ophthalmology discovery and pre-clinical development at Alcon Labs, Inc. The company seeks early-stage assets translated from other diseases and develops select candidates through human clinical proof of concept.

Key Contact
NameTitleE-Mail
Paul G. ChaneyCEO


Funding Events
DateAmountTypeInvestors
10/09/17$11,000,000Series B Third Rock Ventures
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.